Abstract
Human Papillomavirus (HPV)-mediated cervical cancer is a leading cause of morbidity and mortality in women worldwide, including Indian women. Cervical cancer control and prevention strategies are being adopted in developing nations to reduce the increasing burden of HPV infection in the vaccine era. The present study, therefore, aimed to evaluate cervical cancer awareness and knowledge of Gardasil vaccination in North Indian women. A pilot survey was conducted among 103 women of North Indian ethnicity residing in Lucknow/adjoining areas in state of Uttar Pradesh, during routine screening/clinic visits from June 2012 to December 2012. The study subjects were interviewed in either Hindi or English; subsequently the awareness of HPV-mediated cervical cancer and knowledge of Gardasil vaccination was assessed in terms of “yes”, “no” and “no response”. The study was approved by the Institutional Review Board. Written informed consent was taken from the participants. Overall, the response of participants (n = 103) in our single-centre survey-based pilot study was well-defined. The response regarding HPV-mediated cervical cancer awareness in terms of “yes”, “no” and “no response” among the study subjects was 43.7, 44.7 and 11.6 %, respectively. Furthermore, in response to knowledge of HPV vaccine Gardasil, out of 103 subjects, 28.1 % answered “yes” while 37.9 and 34.0 % stated “no” and “no response”, respectively. Our pilot survey may help in assessing knowledge of HPV-mediated cervical cancer and Gardasil vaccination awareness in women, and accordingly develop cost-effective cervical cancer control and prevention/public health counseling sessions in a clinical setting.
Similar content being viewed by others
References
Pandey, S., Mittal, R. D., Srivastava, M., Srivastava, K., & Mittal, B. (2010). Cyclooxygenase-2 gene polymorphisms and risk of cervical cancer in North Indian population. IJGC, 20, 625–630.
Vizcaino, A. P., Moreno, V., Bosch, F. X., et al. (2000). International trends in incidence of cervical cancer: II. Squamous—Cell carcinoma. International Journal of Cancer, 86, 429–435.
Walboomers, J. M., Jacobs, M. V., Manos, M. M., et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189, 12–19.
Zur Hausen, H. (2002). Papillomaviruses and cervical cancer. Nature Reviews, 2, 342–350.
Bosch, F. X., Lorincz, A., Munoz, N., et al. (2002). The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology, 55, 244–265.
Ferlay, J., Bray, F., Pisani, P., Parkin, D. M., & GLOBOCAN 2002. (2004). Cancer incidence, mortality and prevalence worldwide, version 2.0. IARC Cancer Base No. 5 Lyon. France: IARC Press.
Dabash, R., Vajpayee, J., Jacob, M., et al. (2005). A strategic assessment of cervical cancer prevention and treatment services in 3 districts of Uttar Pradesh, India. Reproductive Health, 2, 11.
Pandey, S., Mishra, M., & Chandrawati, (2012). Human Papillomavirus screening in North Indian women. APJCP, 13, 4867–4871.
Motoyama, S., Ladines-Llave, C. A., Luis Villanueva, S., & Maruo, T. (2004). The role of human papillomavirus in the molecular biology of cervical carcinogenesis. Kobe Journal of Medical Sciences, 50, 9–19.
Li, T. T., Zhao, L. N., Liu, Z. G., Han, Y., & Fan, D. M. (2005). Regulation of apoptosis by the papillomavirus E6 oncogene. World Journal of Gastroenterology, 11, 931–937.
Miller, A. B. (1992). Cervical cancer screening programmes: Managerial guidelines. Geneva: World Health Organization.
Solomon, D., Schiffman, M., & Tarone, R. (2001). Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. Journal of the National Cancer Institute, 93, 293–299.
Bovicelli, A., Bristow, R. E., & Montz, F. J. (2000). HPV testing: Where are we now? Anticancer Research, 20, 4673–4680.
Villa, L. L., Costa, R. L., Pettac, A., et al. (2005). Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncology, 6, 271–278.
Villa, L. L., Ault, K. A., Guiliano, A. R., et al. (2006). Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine, 24, 5571–5583.
Harper, D. M., Franco, E. L., Wheeler, C., et al. (2006). Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomized control trial. Lancet, 367, 1247–1255.
Harper, D. M., Franco, E. L., Wheeler, C., et al. (2004). Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial. Lancet, 364, 1757–1765.
Villa, L. L., Costa, R. L. R., Petta, C. A., et al. (2007). High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus like particle vaccine through 5 years follow-up. British Journal of Cancer, 6, 1459–1466.
Bharadwaj, M., Hussain, S., Nasare, V., & Das, B. C. (2009). HPV & HPV vaccination: Issues in developing countries. Indian Journal of Medical Research, 130, 327–333.
International Agency for Research on Cancer. (2005). IARC Handbooks of Cancer Prevention. Cervix Cancer Screening. Lyon: IARC Press.
Kjaer, S. K., Sigurdsson, K., Iversen, O. E., et al. (2009). A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prevention Research (Phila), 2, 868–878.
Paavonen, J., Naud, P., Salmeron, J., et al. (2009). Efficacy of human papillomavirus (HPV)-16/18 ASO4-adjuvanated vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomized study in young women. Lancet, 374, 301–314.
Acknowledgments
We acknowledge the assistance provided by the support/clinical staff of Krishna Medical Centre, Lucknow during the survey-based study.
Conflict of interest
The authors state no conflict of interest and have not received any payment in preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pandey, S., Chandravati Human Papillomavirus-Mediated Cervical Cancer Awareness and Gardasil Vaccination: A Pilot Survey Among North Indian Women. J Community Health 38, 907–910 (2013). https://doi.org/10.1007/s10900-013-9697-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10900-013-9697-6